Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$354,884,128
+$79,219,874 QoQ
Shares Held
2,264,447
+25.5% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. NVS ranks #11 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $354,884,128 | 2,264,447 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $275,664,254 | 1,804,676 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $81,708,928 | 592,652 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $68,934,507 | 537,543 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $55,097,905 | 455,317 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $60,571,314 | 543,338 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $41,175,943 | 423,142 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $35,894,978 | 312,076 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $33,834,474 | 317,814 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $39,159,298 | 404,831 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $35,386,043 | 350,461 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $36,659,309 | 359,899 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $39,055,900 | 387,037 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $37,818,900 | 411,075 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $39,529,513 | 435,731 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $41,558,084 | 546,745 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $56,042,964 | 662,995 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $19,181,621 | 218,594 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $23,474,320 | 268,370 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $25,068,428 | 306,535 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $27,568,801 | 302,157 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $24,460,097 | 286,150 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $36,146,951 | 382,791 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $31,128,546 | 357,964 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $30,255,708 | 346,413 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $35,429,420 | 429,708 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||